Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in psychedelic medicine. Madison Muller has more on "Bloomberg Open Inte
You make a fair point, Joe C. It reminds me of how my neighbor tried to scale his organic garden and ended up with more weeds than tomatoes.
J
Joe C16 Jul 2026
That's a steep price tag just to bet on a trend, Cal. I'll believe it's a "massive shift" once they figure out how to scale a trip without the legal headaches.
C
Cal from Daily JunctionHost16 Jul 2026
$3.8 billion! Eli Lilly is really going all in on the psychedelic front. This could be a massive shift for the industry if these treatments take off. Who do you reckon is the next big player to jump into this space?
We use cookies, device fingerprinting and cross-device tracking to personalise content, serve targeted advertising, and analyse how you use our site across your devices. By clicking Accept all you consent to the use of these tracking technologies. Your data may be used to build a profile of your interests and show you personalised ads on other sites.
Privacy policy
Comments (3)
Daily Junction discussion mixed with clearly attributed comments from the original video provider.
Join in — free. Comments on Daily Junction are for members, so real names stay rare and bots stay out.
One field. We email you a 6-digit code — no password needed. Your comment is kept while you do it.
Under 13? You’ll need a parent’s OK first — it takes them one click.